Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage

American Journal of Pathology

Volumn 161, Issue 2, 2002, Pages 373-379

  Berlanga, Jorge ^a   Prats, Pedro ^a   Remirez, Diadelis ^b   Gonzalez, Ricardo ^b   Lopez Saura, Pedro ^a   Aguiar, Jorge ^a   Ojeda, Miriam ^a   Boyle, Joseph J ^c   Fitzgerald, Anthony J ^d   Playford, Raymond J ^c,d  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE; MITOGENIC AGENT; MYELOPEROXIDASE; RECOMBINANT EPIDERMAL GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; GASTROINTESTINAL HEMORRHAGE; HISTOPATHOLOGY; INTESTINE INJURY; ISCHEMIA; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY; TREATMENT OUTCOME;

EID: 0036971421     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64192-2     Document Type: Article

References (40)

1. Zimmerman JE, Knuas WA, Sun X, Wagner DP: Severity stratification and outcome prediction for multisystem organ failure and dysfunction. World J Surg 1996, 20:401-405
2. Nguyen TT, Gilpin DA, Meyer NA, Herndon DN: Current treatment of severely burned patients. Ann Surgery 1996, 1:14-25
3. McNeill JR, Stark RD, Greenway CV: Intestinal vasoconstriction after haemorrhage: role of vasopressin and angiotensin. Am J Physiol 1970, 219:1342-1347
4. Parks DA, Granger DN: Contributions of ischaemia and reperfusion to mucosal lesion formation. Am J Physiol 1986, 250:G749-G753
5. Playford RJ, Marchbank T, Calnan DP, Calam J, Royston P, Batten JJ, Hansen HF: Epidermal growth factor is digested to smaller, less active forms in acidic gastric juice. Gastroenterology 1995, 108:92-101
6. Berlanga J, Caballero ME, Remirez D, Torres A, Valenzuela C, Lodos J, Playford RJ: Epidermal growth factor protects against carbon tetrachloride-induced hepatic injury. Clin Sci 1998, 94:219-223
7. Caballero ME, Berlanga J, Ramirez D, Lopez-Saura P, Gozalez R, Floyd DN, Playford RJ: Epidermal growth factor reduces multiorgan failure induced by thioacetamide. Gut 2001, 48:34-40
8. Calnan DP, Fagbemi A, Berlanga-Acosta J, Marchbank T, Sizer T, Lakhoo K, Edwards AD, Playford RJ: Potency and stability of C- terminal truncated human epidermal growth factor Gut 2000, 47:622-627
9. Baykal A, Kaynaroglu V, Demirpence E, Kilinc K, Sayek I, Sanac Y: Experimental study of the effect of adrenaline tolerance on intestinal ischaemia-reperfusion. Br J Surg 1998, 85:947-950
10. Chiu CJ, McArdle AH, Brown R, Scott MJ, Gurd FN: Intestinal mucosal lesion in low-flow states: a morphological, hemodynamic and metabolic reappraisal. Arch Surg 1970, 101:478-483
11. Satoh K: Serum lipid peroxidation in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978, 90: 37-43
12. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193:265-275
13. Bradley PP, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982, 78:206-209
14. Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN: Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem 1985, 260:2345-2354
15. Biffl WL, Moore EE: Splanchnic ischaemia/reperfusion and multiple organ failure. Br J Anaesth 1996, 77:59-70
16. Granger DN, Korthuis RJ: Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol 1995, 57:311-332
17. Kong SE, Blennerhassett LR, Heel KA, McCauley RD, Hall JC: Ischaemic-reperfusion injury to the intestine. Aust NZ J Surg 1998, 68: 554-561
18. Conteas CN Majumdar APN: The effects of gastrin, epidermal growth factor and somatostatin on DNA synthesis in a small intestinal crypt cell line (IEC-6) Proc Soc Exp Biol Med 1987, 184:307-311
19. Goodlad RA, Lee CY, Wright NA: Cell proliferation in the small intestine and colon of intravenously fed rats: effects of urogastrone-epidermal growth factor. Cell Prolif 1992, 25:393-404
20. Uribe JM, Barret KM: Nonmitogenic actions of growth factors: an integrated view of their role in intestinal physiology and pathophysiology. Gastroenterology 1997, 112:255-268
21. Procaccino F, Reinshagen M, Hoffmann P, Zeeh JM, Lakshmanan J, McRoberts JA, Patel A, French S, Eysselein VE: Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology 1994, 107:12-17
22. Mesa ML, Carrizosa R, Martine Zhonduvilla C, Benito M, Fabregat I: Changes in rat liver gene expression induced by thioacetamide. Protective role of S-adenosyl-L-methionine by a gluthatione dependent mechanism. Hepatology 1996, 23:600-606
23. Carden DL, Granger DN: Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000, 190:255-266
24. Dwir O, Kansas GS, Alon R: An activated L-selectin mutant with conserved equilibrium binding properties but enhanced ligand recognition under shear flow. J Biol Chem 2000, 275:18682-18691
25. Solic N, Davies DE: Differential effects of EGF and amphiregulin on adhesion molecule expression and migration of colon carcinoma cells. Exp Cell Res 1997, 234:465-476
26. Bown MJ, Nicholson ML, Bell PR, Sayers RD: Cytokines and inflammatory pathways in the pathogenesis of multiple organ failure following abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2001, 22:485-495
27. Souza DG, Cassali GD, Poole S, Teixeira MM: Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury. Br J Pharmacol 2001, 134:985-994
28. Crompton M: The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999, 15:233-249
29. Sandoval M, Zhang XJ, Liu X, Mannick EE, Clark DA, Miller MJ: Peroxynitrite-induced apoptosis in T84 and RAW 264.7 cells: attenuation by L-ascorbic acid. Free Radic Biol Med 1997, 22:489-495
30. Price LT, Chen Y, Frank L: Epidermal growth factor increases antioxidant enzyme and surfactant system development during hyperoxia and protects fetal lungs in vitro from hyperoxic toxicity. Pediatric Res 1993, 34:577-585
31. Lieberthal W, Triaca V, Koh JS, Pagano PJ, Levine JS: Role of superoxide in apoptosis induced by growth factor withdrawal. Am J Physiol 1998, 275:F691-F702
32. Pillai SB, Hinman CE, Luquette MH, Nowicki PT, Besner GE: Heparinbinding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury. J Surg Res 1999, 87:225-231
33. Heck DE, Laskin DL, Gardner CR, Laskin JD: Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem 1992, 267:21277-21280
34. Saroseik J, Bilski J, Murty VLN, Slomiany A, Slomiany BL: Role of epidermal growth factor in the maintenance of physico-chemical characteristics of oral and gastric mucus coat. Biochem Biophys Res Commun 1988, 152:1421-1427
35. Gan BS, Hollenberg MD, MacCannel KL, Lederis K, Winkler ME, Derynck R: Distinct vascular actions of epidermal growth factor- urogastrone and transforming growth factor α. J Pharmacol Exp Ther 1987, 242:331-337
36. Tepperman BL, Soper BD: Effect of epidermal growth factor, transforming growth factor α and nerve growth factor on gastric mucosal integrity and microcirculation in the rat. Regul Pept 1994, 50:13-21
37. Logan SK, Falasca M, Hu P, Schlessinger J: Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-jun N-terminal kinase signalling pathway. Mol Cell Biol 1997, 17: 5784-5790
38. Gibson S, Tu S, Oyer R, Anderson SM, Johnson GL: Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation J Biol Chem 1999, 274:17612-17618
39. Sullivan PB, Lewidon PJ, Oppenheimer SJ, Cheng C, Goodlad RA, Wright NA: A pilot study of the safety and efficacy of epidermal growth factor in the treatment of necrotising enterocolitis. Gut 1997, 41 (Suppl 3):A69
40. Sinha A, Nightingale J, West KP, Berlanga-Acosta J, Playford RJ: Epidermal growth factor enemas are effective in the treatment of left-sided ulcerative colitis. Gastroenterology 2001, 120(Suppl 1):A11